Masimo Co. (MASI) Director Steven Barker Sells 10,000 Shares

Masimo Co. (NASDAQ:MASI) Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $145.00, for a total transaction of $1,450,000.00. Following the sale, the director now owns 74,832 shares of the company’s stock, valued at approximately $10,850,640. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Steven Barker also recently made the following trade(s):

  • On Monday, April 1st, Steven Barker sold 10,000 shares of Masimo stock. The stock was sold at an average price of $140.00, for a total transaction of $1,400,000.00.
  • On Thursday, March 28th, Steven Barker sold 10,000 shares of Masimo stock. The shares were sold at an average price of $135.00, for a total transaction of $1,350,000.00.
  • On Monday, February 25th, Steven Barker sold 5,877 shares of Masimo stock. The shares were sold at an average price of $130.00, for a total transaction of $764,010.00.

Shares of MASI traded down $4.81 during mid-day trading on Friday, reaching $140.77. 375,135 shares of the stock traded hands, compared to its average volume of 452,100. The firm has a market capitalization of $7.69 billion, a P/E ratio of 46.46, a price-to-earnings-growth ratio of 2.82 and a beta of 1.12. Masimo Co. has a 1 year low of $96.14 and a 1 year high of $147.91.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Monday, May 6th. The medical equipment provider reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.04. Masimo had a net margin of 22.49% and a return on equity of 18.61%. The firm had revenue of $231.70 million during the quarter, compared to analyst estimates of $223.67 million. During the same period in the previous year, the business earned $0.75 EPS. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. Research analysts forecast that Masimo Co. will post 3.12 earnings per share for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC lifted its holdings in shares of Masimo by 7.4% during the 1st quarter. FMR LLC now owns 4,178,808 shares of the medical equipment provider’s stock worth $577,845,000 after acquiring an additional 289,246 shares during the last quarter. Vanguard Group Inc raised its position in Masimo by 2.7% in the third quarter. Vanguard Group Inc now owns 4,147,708 shares of the medical equipment provider’s stock worth $516,556,000 after acquiring an additional 109,065 shares during the period. AQR Capital Management LLC raised its position in Masimo by 44.1% in the first quarter. AQR Capital Management LLC now owns 834,469 shares of the medical equipment provider’s stock worth $114,064,000 after acquiring an additional 255,499 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd raised its position in Masimo by 12.6% in the fourth quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 779,500 shares of the medical equipment provider’s stock worth $83,694,000 after acquiring an additional 87,476 shares during the period. Finally, Victory Capital Management Inc. raised its position in Masimo by 13.3% in the fourth quarter. Victory Capital Management Inc. now owns 726,329 shares of the medical equipment provider’s stock worth $77,986,000 after acquiring an additional 85,255 shares during the period. 81.79% of the stock is owned by institutional investors.

MASI has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of Masimo from a “sell” rating to a “hold” rating in a research note on Wednesday, January 23rd. BidaskClub upgraded shares of Masimo from a “buy” rating to a “strong-buy” rating in a research note on Thursday, January 31st. Needham & Company LLC reiterated a “buy” rating and issued a $139.00 price objective on shares of Masimo in a research note on Friday, February 1st. Piper Jaffray Companies reiterated an “overweight” rating and issued a $140.00 price objective on shares of Masimo in a research note on Wednesday, February 27th. Finally, BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating and set a $134.50 price objective for the company. in a research note on Tuesday, April 16th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $149.75.

ILLEGAL ACTIVITY NOTICE: “Masimo Co. (MASI) Director Steven Barker Sells 10,000 Shares” was reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://transcriptdaily.com/2019/05/17/masimo-co-masi-director-steven-barker-sells-10000-shares-2.html.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Recommended Story: Call Option Volume

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.